Accelerating Value to an EEG-based solution for Remote Trials, during COVID-19 (AVERT COVID-19)

新冠肺炎疫情引发的全球危机对医疗保健产生了深远而广泛的影响。优先事项必然发生了变化，资源已被转用来协助应对危机。对于成千上万参加正在进行或计划中的临床试验的患者来说，重要的是保持安全，同时尽可能减少对正在进行的治疗的干扰，并保留他们对药物或生物医学设备开发的宝贵科学贡献。BrainWaveBank的平台适用于一系列神经精神和神经退行性疾病，旨在跟踪基本药物机制的测量、治疗组的分层和治疗反应的早期检测。它包括一个易于使用的可穿戴耳机，以及在平板电脑上呈现的测试认知不同方面的游戏，产生基于大脑的神经生理机制和认知功能的生物标记物。在这个项目中，BrainWaveBank将加快交付平台的速度，这意味着参与者将不必离开自己的家，安全舒适地进行数据收集，并在新冠肺炎和其他平台的工作限制期间提供可靠、用户友好的解决方案。

The global crisis caused by the COVID-19 pandemic has had a profound and widespread effect on healthcare. Priorities have necessarily shifted, and resources have been diverted to assist with the crisis. For many thousands of patients enrolled in ongoing or planned clinical trials, it is vital to maintain safety but also minimise, where possible, disruption to ongoing therapy and preserve their valuable scientific contribution towards drug or biomedical device development.BrainWaveBank's platform is suitable for use across a range of neuropsychiatric and neurodegenerative disorders, designed to track measurement of basic drug mechanisms, stratification of treatment groups, and early detection of response to therapies.It consists of an easy-to-use, wearable headset, accompanied by games presented on a tablet that test different aspects of cognition, yielding brain-based biomarkers of neurophysiological mechanisms and cognitive function.In this project, BrainWaveBank will accelerate the pathway to deliver their platform in a manner that means participants will not have to leave the safety and comfort of their own home, enabling continuing data collection and providing a dependable, user friendly solution during the working restrictions of COVID-19 and beyond.